Bioprocessing Companies Push Limits of Upstream Technologies
Goal Is to Maximize Efficiency in Bioprocess Operations
Supplement: Visions of a Continuous Bioprocess Future
Challenges Remain in the Switch from Fed-Batch Biomanufacturing Operations
Scaling Up Cell Therapy Manufacturing
Moving Forward with an Early-on Strategy
Bispecific Playgrounds? No, Factory Floors
Developers Prepare for Future Biologics Work by Exploring a Multitude of Antibody Formats
For full access to this article login to GEN Select now.
Supplement: Immunotherapy Encompasses More Than Immuno-oncology
The Future of Medicine Lies in Treatments that Work in Concert with the Body’s Immune System
- Immuno-oncology has stolen the spotlight, but it is just one aspect of immunotherapy, one of the hottest trends in biopharma. According to Sapna Jha, a lead healthcare and life sciences analyst from Technavio, a market research company, cancer immunotherapies offer “better efficacy, enhanced safety, and higher patient adherence ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.